ReportGem ReportGem

U.S. COMPANY FILING

GILEAD SCIENCES, INC. — Form 10-K filed 2026-02-24

Filed: 2026-02-24Company: GILEAD SCIENCES, INC.Ticker: GILDExchange: NasdaqForm: 10-KReport period: 2025-12-31SEC accession: 0000882095-26-000006Event: earningsMateriality: 85

Filing text preview

Gilead's 2025 revenues rose 2% to $29.4B, with net income of $8.5B and diluted EPS of $6.78, a significant increase from 2024 due to non-repeating IPR&D expenses and higher unrealized gains. R&D expenses decreased 2%, SG&A decreased 5%. The company declared a quarterly dividend of $0.82 per share and plans $32B U.S. investment through 2030.

This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.

Open filing record

Related research and intelligence

Official SEC filing2026-02-24Top economists warn of wealth inequality in U.S. surpassing Gilded Age2026-08-19FORM 10-Q2026-08-06 · 10-QFORM 8-K2026-08-04 · 8-KFORM 10-Q2026-05-07 · 10-QFORM 8-K2026-05-07 · 8-KFORM 8-K2026-02-10 · 8-KFORM 10-Q2025-11-07 · 10-Q